A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma.

Morrell, L E; Lee, Y J; Hurley, J; Arias, M; Mies, C; Richman, S P; Fernandez, H; Donofrio, K A; Raub, W A; Cassileth, P A

Morrell, L E; Lee, Y J; Hurley, J; Arias, M; Mies, C; Richman, S P; Fernandez, H; Donofrio, K A; Raub, W A; Cassileth, P A.

Affiliation

Morrell LE; Boca Raton Community Hospital, Florida, USA.

Cancer ; 82(3): 503-11, 1998 Feb 01.

Article in En | MEDLINE | ID: mdl-9452268

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Cisplatin/administration & dosage; Cisplatin/adverse effects; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Female; Humans; Methotrexate/administration & dosage; Methotrexate/adverse effects; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Vinblastine/administration & dosage; Vinblastine/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Cancer Year: 1998 Document type: Article

Search on Google

XML

PubMed Links